Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-03-13 @ 5:34 PM
Study NCT ID:
NCT00620659
Status:
TERMINATED
Last Update Posted:
2015-05-13
First Post:
2008-01-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
Sponsor:
Merck Sharp & Dohme LLC
Organization: